Isofol Medical
Clinical-stage biotech developing a folate-based therapy to enhance cancer treatments.
ISOFOL | ST
Overview
Corporate Details
- ISIN(s):
- SE0009581051
- LEI:
- 549300MCXYAHG7VBHX75
- Country:
- Sweden
- Address:
- C/O Biotech Center, Arvid Wallgrens, 413 46 Göteborg
- Website:
- https://isofolmedical.com/
Description
Isofol Medical is a clinical-stage biotechnology company dedicated to improving treatments for severe forms of cancer. The company's primary focus is the development of its lead drug candidate, arfolitixorin. This next-generation, folate-based therapy is designed to enhance the efficacy of standard cancer treatments, such as chemotherapy. Arfolitixorin is the active metabolite of commonly used folate-based drugs, potentially offering a therapeutic benefit to a broader patient population by bypassing complex metabolic activation steps. The company's goal is to help more patients respond better to their treatment, thereby improving their prognosis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-01-30 13:46 |
Isofol has obtained a request to call for an extraordinary general meeting
|
English | 59.5 KB | ||
| 2023-01-30 13:46 |
Isofol har erhållit en begäran om att kalla till extra bolagsstämma
|
Swedish | 59.1 KB | ||
| 2023-01-19 16:00 |
Kallelse till extra bolagsstämma i Isofol Medical AB (publ) den 13 februari 2023
|
Swedish | 153.8 KB | ||
| 2023-01-19 16:00 |
Notice convening the extraordinary general meeting in Isofol Medical AB (publ) …
|
English | 173.9 KB | ||
| 2023-01-19 13:45 |
Isofols styrelse avser kalla till extra bolagsstämma med förslag till utdelning…
|
Swedish | 99.7 KB | ||
| 2023-01-19 13:45 |
Isofol Medical’s Board of Directors intends to call an extraordinary general me…
|
English | 120.7 KB | ||
| 2022-12-21 13:30 |
Isofol Medical CFO and Deputy CEO Gustaf Albèrt to step down during 2023
|
English | 63.2 KB | ||
| 2022-12-21 13:30 |
Isofol Medicals CFO och vice vd Gustaf Albèrt lämnar under 2023
|
Swedish | 61.9 KB | ||
| 2022-11-28 17:55 |
Isofol Medicals vd Ulf Jungnelius slutar den 1 juni 2023
|
Swedish | 64.0 KB | ||
| 2022-11-28 17:55 |
CEO Ulf Jungnelius to leave Isofol Medical on June 1, 2023
|
English | 64.6 KB | ||
| 2022-11-11 08:00 | Swedish | 111.5 KB | |||
| 2022-11-11 08:00 | English | 144.9 KB | |||
| 2022-11-03 15:15 |
Isofol har utsett valberedningen inför årsstämman 2023
|
Swedish | 114.1 KB | ||
| 2022-11-03 15:15 |
Isofol appoints nomination committee ahead of the Annual General Meeting 2023
|
English | 114.7 KB | ||
| 2022-10-20 10:41 | English | 35.9 KB |
Automate Your Workflow. Get a real-time feed of all Isofol Medical filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Isofol Medical
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Isofol Medical via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-11 | Magnus Hurst | Other | Buy | 35,000 | 24,150.00 SEK |
| 2022-09-12 | AB Windar | Other | Buy | 500,000 | 305,000.00 SEK |
| 2021-12-09 | Tony Gustavsson | Other | Sell | 58,767 | 858.00 SEK |
| 2021-12-09 | Tony Gustavsson | Other | Sell | 58,767 | 152.79 SEK |
| 2021-06-14 | HealthCom GmbH | Other | Buy | 233,336 | 1,493,350.40 SEK |
| 2021-06-10 | Gustaf Albèrt | Other | Other | 15,153 | 96,979.20 SEK |
| 2020-11-23 | Tony Gustavsson | Other | Buy | 58,767 | 43,487.58 SEK |
| 2020-11-23 | Tony Gustavsson | Other | Buy | 58,767 | 29,971.17 SEK |
| 2020-11-16 | Sven Eriksson | Other | Sell | 58,767 | 43,487.58 SEK |
| 2020-11-16 | Sven Eriksson | Other | Sell | 58,767 | 29,971.17 SEK |
Peer Companies
